| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2598.72 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 1965.86 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 1769.41 | 98 |
| GSM780719 | Untreated after 4 days (C1_2) | 2462.79 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2160.86 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 1885.62 | 98 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1601.88 | 97 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2568.5 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2184.97 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1767.34 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2716.11 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2457.47 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2434.25 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2424.06 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2728.34 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2535.25 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 2452.79 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2602.65 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2440.26 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2302.6 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2111.06 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2347.82 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2164.56 | 98 |